Drug intelligence / Profile preview

ulva lactuca polysaccharide

Development stage
Preclinical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Ulva lactuca polysaccharide (ULP), also known as ulvan, is a sulfated heteropolysaccharide extracted from the green macroalga *Ulva lactuca* (commonly known as sea lettuce). It is composed of rhamnose, xylose, glucose, galactose, and uronic acid, with significant sulfate ester groups. Preclinical studies have demonstrated that ULP possesses diverse biological activities, including immunomodulatory, antioxidant, anti-inflammatory, and anti-tumor properties. In models of hepatocellular carcinoma (HCC), ULP has been shown to suppress tumor growth by restructuring the gut microbiota, altering serum lipid metabolites (such as increasing lysophosphatidylserine and decreasing lysophosphatidic acid), inducing CD5L expression, and activating the complement cascade. It is also investigated for its potential in alleviating constipation and oxidative stress-induced renal injury.

Other names
Ulva lactuca polysaccharide extractUlva polysaccharideulvan
02

Targets

ERKJNK (Mitogen-activated protein kinase kinase kinase family)LY96 (Myeloid differentiation factor 2)NF-κBTLR2 (Toll-like Receptor 2)TLR4 (Toll-like receptor 4)RK (Ribokinase)

Beyond the preview

Go deeper on ulva lactuca polysaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ulva lactuca polysaccharide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call